HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acrylamide

This article was originally published in The Rose Sheet

Executive Summary

Center for the Evaluation of Risks to Human Reproduction concludes there is "negligible concern" for adverse reproductive and developmental effects from exposure to acrylamide in the general population and there is "minimal concern" for acrylamide-induced heritable effects. There is "some concern" for adverse reproductive and developmental effects from occupational exposure to the chemical, the panel says. CERHR assessed the safety of acrylamide, an ingredient used in some cosmetics, during a meeting in May (1"The Rose Sheet" May 17, 2004, p. 9). The expert panel report from this evaluation will be available in about four weeks...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS012178

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel